These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32087357)

  • 41. Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
    Goldenberg GR; Barsheshet A; Bishara J; Kadmon E; Omelchencko A; Strasberg B; Golovchiner G
    J Interv Card Electrophysiol; 2020 Jun; 58(1):113-118. PubMed ID: 31227978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of antibacterial envelope in prevention of cardiovascular implantable electronic device infections in high-risk patients: A systematic review and meta-analysis.
    Ullah W; Nadeem N; Haq S; Thelmo FL; Abdullah HM; Haas DC
    Int J Cardiol; 2020 Sep; 315():51-56. PubMed ID: 32291170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.
    Traykov V; Bongiorni MG; Boriani G; Burri H; Costa R; Dagres N; Deharo JC; Epstein LM; Erba PA; Snygg-Martin U; Nielsen JC; Poole JE; Saghy L; Starck C; Strathmore N; Blomström-Lundqvist C
    Europace; 2019 Aug; 21(8):1270-1279. PubMed ID: 31209483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Redo procedures and chronic renal dysfunction are associated with higher risk of cardiac electronic device infections.
    Morani G; Mugnai G; Bolzan B; Morosato M; Tomasi L; Ferrari S; Vassanelli C
    Minerva Cardioangiol; 2018 Jun; 66(3):225-232. PubMed ID: 29308851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infectious complications in patients with cardiac implantable electronic devices: risk factors, prevention, and prognosis.
    Polewczyk A; Jacheć W; Polewczyk AM; Tomasik A; Janion M; Kutarski A
    Pol Arch Intern Med; 2017 Sep; 127(9):597-607. PubMed ID: 28724879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rate of device-related infections using an antibacterial envelope in patients undergoing cardiac resynchronization therapy reoperations.
    Frausing MHJP; Nielsen JC; Johansen JB; Jørgensen OD; Gerdes C; Olsen T; Kronborg MB
    Europace; 2022 Mar; 24(3):421-429. PubMed ID: 34431989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in cardiac implantable electronic device infection prevention: should we push the envelope?
    Lambert CT; Wilkoff BL; Tarakji KG
    Future Cardiol; 2018 Sep; 14(5):359-366. PubMed ID: 30062906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chlorhexidine gluconate pocket lavage to prevent cardiac implantable electronic device infection in high-risk procedures.
    Diaz JC; Braunstein ED; Cañas F; Duque M; Marín JE; Aristizabal J; Niño CD; Bastidas O; Hoyos C; Steiger NA; Matos CD; Sauer WH; Romero JE
    Heart Rhythm; 2023 Dec; 20(12):1674-1681. PubMed ID: 37598986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.
    Krahn AD; Longtin Y; Philippon F; Birnie DH; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; van Vlies B; Wang J; Exner DV; Dorian P; Parkash R; Alings M; Connolly SJ
    J Am Coll Cardiol; 2018 Dec; 72(24):3098-3109. PubMed ID: 30545448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
    Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.
    Birnie DH; Wang J; Alings M; Philippon F; Parkash R; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; Exner DV; Dorian P; Connolly SJ; Longtin Y; Krahn AD
    J Am Coll Cardiol; 2019 Dec; 74(23):2845-2854. PubMed ID: 31806127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.
    Arana-Rueda E; Pedrote A; Frutos-López M; Acosta J; Jauregui B; García-Riesco L; Arce-León Á; Gómez-Pulido F; Sánchez-Brotons JA; Gutiérrez-Carretero E; de Alarcón-González A
    Clin Cardiol; 2017 Oct; 40(10):892-898. PubMed ID: 28636098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of Pocket Infection Postcardiac Device Implantation Using Antibiotic versus Saline Solution for Pocket Irrigation.
    Lakshmanadoss U; Nuanez B; Kutinsky I; Khalid R; Haines DE; Wong WS
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):978-84. PubMed ID: 27440320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Burden of disease and costs of infections associated with cardiac implantable electronic devices.
    Sgreccia D; Vitolo M; Valenti AC; Manicardi M; Boriani G
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jan; 22(1):7-16. PubMed ID: 34517745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of patients undergoing a cardiac implantable electronic device implantation following a recent non-device-related infection.
    Chen HC; Chen YL; Lee WC; Tsai TH; Pan KL; Lin YS; Chen MC
    J Hosp Infect; 2020 Jun; 105(2):272-279. PubMed ID: 32057789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and risk factors for cardiac implantable electronic device infection in current clinical settings in a Japanese population: A 20-year single-center observational study.
    Ishiguchi H; Ishikura M; Yoshida M; Imoto K; Sonoyama K; Kawabata T; Ishihara Y; Yoshiga Y; Shimizu A; Oda T
    J Cardiol; 2020 Jul; 76(1):115-122. PubMed ID: 32037251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study.
    Klug D; Balde M; Pavin D; Hidden-Lucet F; Clementy J; Sadoul N; Rey JL; Lande G; Lazarus A; Victor J; Barnay C; Grandbastien B; Kacet S;
    Circulation; 2007 Sep; 116(12):1349-55. PubMed ID: 17724263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.